SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

SAB Biotherapeutics, Inc. (SABSW) News

Follow SAB Biotherapeutics, Inc. (SABSW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SABSW Asset equity Sector Markets 90 days 4 Last 0.0001 Updated Nov 05, 2026, 12:30 PM UTC Open live news feed Open SABSW chart & news
M SAB BIO Reports Q3 2026 Financial Results and Business Highlights Adult and adolescent cohorts are fully enrolled in the registrational SAFEGUARD study of SAB-142. EQUITY | Nov 05, 2026, 12:30 PM UTC L SAB Biotherapeutics Receives FDA Fast Track Designation for SAB-142 The FDA granted Fast Track designation to SAB-142 for Stage 3 type 1 diabetes. REGULATION | Oct 13, 2026, 12:30 PM UTC L SABS SABSW - SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes SABS SABSW - SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes NEWS | Sep 22, 2026, 12:30 PM UTC L SABS SABSW - SAB BIO to Participate in Upcoming Investor Conferences SABS SABSW - SAB BIO to Participate in Upcoming Investor Conferences EQUITY | Sep 01, 2026, 12:30 PM UTC L SABS SABSW - SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights SABS SABSW - SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights EARNINGS | Aug 06, 2026, 11:30 AM UTC L SABS SABSW - SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET - Click For Re SABS SABSW - SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET EARNINGS | Jul 30, 2026, 12:30 PM UTC